What is RRX's health score?

REGAL REXNORD CORP (RRX) has a TradeApes health score of 66 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is RRX's estimated fair value?

Based on our 5-year discounted cash flow model, REGAL REXNORD CORP's estimated fair value is $N/A per share. This is a model estimate, not a price target or investment recommendation.

Is RRX undervalued or overvalued?

Our model currently rates RRX as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for RRX... Refresh in a moment for the full analysis.

REGAL REXNORD CORP (RRX)

Technology Overvalued low healthy

$201.76

Updated: 2026-05-30

TradeApes Score

Financial Strength

75 Strong

Operating Trend

73 Healthy

Relative Value

55 Mixed

Capital Allocation

50 Mixed

Risk

80 Strong

Key Findings

+ Historically cheap — EV/EBITDA in bottom 25% of its 5-year range

Unlock Full Report →

− Extreme P/E — above 45×, very high expectations embedded in price

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.